237 related articles for article (PubMed ID: 8609538)
1. Staphylococcus aureus infections in haemodialysis patients: pathophysiology and use of nasal mupirocin for prevention.
Boelaert JR; Van Landuyt HW; De Baere YA; Deruyter MM; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
J Chemother; 1995 Jul; 7 Suppl 3():49-53. PubMed ID: 8609538
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus infection in haemodialysis patients. Mupirocin as a topical strategy against nasal carriage: a review.
Boelaert JR
J Chemother; 1994 Apr; 6 Suppl 2():19-24. PubMed ID: 7799051
[TBL] [Abstract][Full Text] [Related]
3. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients.
Boelaert JR; Van Landuyt HW; Godard CA; Daneels RF; Schurgers ML; Matthys EG; De Baere YA; Gheyle DW; Gordts BZ; Herwaldt LA
Nephrol Dial Transplant; 1993; 8(3):235-9. PubMed ID: 8385291
[TBL] [Abstract][Full Text] [Related]
4. [Epidemiology and prevention of Staphylococcus aureus infections during hemodialysis].
Boelaert JR; Van Landuyt HW; De Baere YA; Gheyle DW; Daneels RF; Schurgers ML; Matthys EG; Gordts BZ
Nephrologie; 1994; 15(2):157-61. PubMed ID: 8047204
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcus aureus nasal carriage in hemodialysis patients. Its role in infection and approaches to prophylaxis.
Chow JW; Yu VL
Arch Intern Med; 1989 Jun; 149(6):1258-62. PubMed ID: 2658896
[TBL] [Abstract][Full Text] [Related]
6. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
7. Lack of efficacy of mupirocin in the prevention of infections with Staphylococcus aureus in liver transplant recipients and candidates.
Paterson DL; Rihs JD; Squier C; Gayowski T; Sagnimeni A; Singh N
Transplantation; 2003 Jan; 75(2):194-8. PubMed ID: 12548122
[TBL] [Abstract][Full Text] [Related]
8. Effect of mupirocin treatment on nasal, pharyngeal, and perineal carriage of Staphylococcus aureus in healthy adults.
Wertheim HF; Verveer J; Boelens HA; van Belkum A; Verbrugh HA; Vos MC
Antimicrob Agents Chemother; 2005 Apr; 49(4):1465-7. PubMed ID: 15793127
[TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization.
Peña C; Fernández-Sabe N; Domínguez MA; Pujol M; Martinez-Castelao A; Ayats J; Gudiol F; Ariza J
J Hosp Infect; 2004 Sep; 58(1):20-7. PubMed ID: 15350709
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
Laupland KB; Conly JM
Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
12. Prevention of Staphylococcus aureus burn wound colonization by nasal mupirocin.
Kooistra-Smid AM; van Zanten E; Ott A; van Dijk SR; Beerthuizen GI; Vogels WH; van Belkum A; Verbrugh HA
Burns; 2008 Sep; 34(6):835-9. PubMed ID: 18242873
[TBL] [Abstract][Full Text] [Related]
13. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.
Perl TM; Cullen JJ; Wenzel RP; Zimmerman MB; Pfaller MA; Sheppard D; Twombley J; French PP; Herwaldt LA;
N Engl J Med; 2002 Jun; 346(24):1871-7. PubMed ID: 12063371
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of mupirocin in the eradication of Staphylococcus aureus nasal carriage in human immunodeficiency virus disease.
Martin JN; Perdreau-Remington F; Kartalija M; Pasi OG; Webb M; Gerberding JL; Chambers HF; Täuber MG; Lee BL
J Infect Dis; 1999 Sep; 180(3):896-9. PubMed ID: 10438389
[TBL] [Abstract][Full Text] [Related]
15. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
Al-Hwiesh AK; Abdul Rahman IS
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
[TBL] [Abstract][Full Text] [Related]
16. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
17. Mupirocin treatment of nasal staphylococcal colonization.
Scully BE; Briones F; Gu JW; Neu HC
Arch Intern Med; 1992 Feb; 152(2):353-6. PubMed ID: 1739366
[TBL] [Abstract][Full Text] [Related]
18. Elimination of Staphylococcus aureus in hemodialysis patients.
Bommer J; Vergetis W; Andrassy K; Hingst V; Borneff M; Huber W
ASAIO J; 1995; 41(1):127-31. PubMed ID: 7727815
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus nasal carriage and infection in patients on hemodialysis. Efficacy of antibiotic prophylaxis.
Yu VL; Goetz A; Wagener M; Smith PB; Rihs JD; Hanchett J; Zuravleff JJ
N Engl J Med; 1986 Jul; 315(2):91-6. PubMed ID: 3523240
[TBL] [Abstract][Full Text] [Related]
20. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]